The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Survival in Portopulmonary Hypertension: Mayo Clinic Experience Categorized by Treatment Subgroups
Open accessAbstract
To determine the natural history of portopulmonary hypertension (POPH), a retrospective screening-right heart catheterization-survival analysis of patients was performed. We categorized patients by three treatment subgroups: (1) no therapy for pulmonary hypertension (PH) or liver transplantation (LT), (2) therapy for PH alone and (3) therapy for PH followed by LT. Seventy-four patients were identified between 1994 and 2007. Nineteen patients received no therapy for PH and no LT representing the natural history of POPH. Five-year survival was 14%, and 54% had died within 1 year of diagnosis. Five-year survival in 43 patients receiving therapy for PH but no LT was 45%, and 12% had died within 1 year of diagnosis. Twelve patients underwent LT and 5-year survival for the nine receiving therapy for PH was 67% versus 25% in the three who were not pretreated with prostacyclin therapy. The survival of untreated patients with POPH was poor. Subgroups of patients selected to medical treatment with or without LT had better long-term survival. Mortality did not correlate with baseline hemodynamic variables, type of liver disease or severity of hepatic dysfunction. Medical therapy for POPH should be considered in all patients with POPH, but the treatment effects and impact on those considered for LT still requires well-designed, prospective study before practice guidelines can be suggested.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical classification of pulmonary hypertension
Simonneau, G., Galiè, N., Rubin, L. J., Langleben, D., Seeger, W., Domenighetti, G., Gibbs, S., Lebrec, D., Speich, R., Beghetti, M., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.037 · Cited by 1,897
Pulmonary–Hepatic vascular Disorders (PHD)
Rodríguez-Roisin, R., Krowka, M. J., Hervé, P., & Fallon, M. B. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00010904 · Cited by 796
Self-citationKrowka, M. J., Plevak, D. J., Findlay, J. Y., Rosen, C. B., Wiesner, R. H., & Krom, R. A. F. (2000) · Liver Transplantation · doi:10.1053/jlts.2000.6356 · Cited by 611
Self-citationHadengue, A., Benhayoun, M. K., Lebrec, D., & Benhamou, J.-P. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90225-a · Cited by 499
Krowka, M. J., Mandell, S. M., Ramsay, M. A. E., Kawut, S. M., Fallon, M. B., Manzarbeitia, C., Pardo, M., Marotta, P., Üemoto, S., Stoffel, M. P., et al. (2004) · Liver Transplantation · doi:10.1002/lt.20016 · Cited by 443
Self-citationPortopulmonary hypertension: Results from a 10-year screening algorithm
Krowka, M. J., Swanson, K. L., Frantz, R. P., McGoon, M. D., & Wiesner, R. H. (2006) · Hepatology · doi:10.1002/hep.21431 · Cited by 385
Self-citationPulmonary vascular disorders in portal hypertension
Herve, P., Lebrec, D., Brenot, F., Simonneau, G., Humbert, M., Sitbon, O., & Duroux, P. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.11051153 · Cited by 360
Colle, I. O., Moreau, R., Godinho, E., Belghiti, J., Ettori, F., Cohen-Solal, A., Mal, H., Bernuau, J., Marty, J., Lebrec, D., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50060 · Cited by 354
Krowka, M. J., Frantz, R. P., McGoon, M. D., Severson, C., Plevak, D. J., & Wiesner, R. H. (1999) · Hepatology · doi:10.1002/hep.510300307 · Cited by 292
Self-citationSildenafil treatment for portopulmonary hypertension
Reichenberger, F., Voswinckel, R., Steveling, E., Enke, B., Kreckel, A., Olschewski, H., Grimminger, F., Seeger, W., & Ghofrani, H. A. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00030206 · Cited by 214
Cited by
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv317 · Cited by 6,931
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01032-2015 · Cited by 3,172
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
Angeli, P., Bernardi, M., Villanueva, C., Francoz, C., Mookerjee, R. P., Trebicka, J., Krag, A., Laleman, W., & Gines, P. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.024 · Cited by 2,905
Abman, S. H., Hansmann, G., Archer, S. L., Ivy, D. D., Adatia, I., Chung, W. K., Hanna, B. D., Rosenzweig, E. B., Raj, J. U., Cornfield, D., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000329 · Cited by 1,164
EASL Clinical Practice Guidelines: Liver transplantation
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.10.006 · Cited by 1,082
Metadata
- Authors
- Swanson, K. L., Wiesner, R. H., Nyberg, S. L., Rosen, C. B., & Krowka, M. J.
- Venue
- American Journal of Transplantation
- Publisher
- Elsevier BV
- Published
- 2008-11
- Volume
- 8
- Issue
- 11
- Pages
- 2445-2453
- ISSN
- 1600-6135 (ISSN-L)
- OpenAlex
- W2026687293
- Cited by
- 339
- References
- 19
- FWCI
- 12.52
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Survival in Portopulmonary Hypertension: Mayo Clinic Experience Categorized by Treatment Subgroups. https://app.cochat.ai/papers/10.1111/j.1600-6143.2008.02384.x
- The paper
- Swanson, K. L., Wiesner, R. H., Nyberg, S. L., Rosen, C. B., & Krowka, M. J. (2008). Survival in Portopulmonary Hypertension: Mayo Clinic Experience Categorized by Treatment Subgroups. American Journal of Transplantation. https://doi.org/10.1111/j.1600-6143.2008.02384.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.